Shan Kang Selected Research

Shan Kang Research Topics

Disease

23	Neoplasms (Cancer) 01/2024 - 12/2007
17	Ovarian Epithelial Carcinoma 01/2023 - 08/2004
15	Endometriosis 01/2021 - 09/2005
10	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2023 - 12/2019
9	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 11/2004
6	Adenomyosis 07/2010 - 09/2005
5	Neoplasm Metastasis (Metastasis) 08/2023 - 07/2009
4	Endometrial Neoplasms (Endometrial Cancer) 01/2024 - 01/2016
4	Adenocarcinoma 12/2023 - 03/2014
4	Lymphatic Metastasis 01/2023 - 12/2019
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 12/2019
2	Infertility (Sterility) 01/2021 - 10/2014
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 12/2018
2	Carcinogenesis 01/2019 - 07/2012
2	Breast Neoplasms (Breast Cancer) 12/2013 - 02/2013
2	Type 2 Diabetes Mellitus (MODY) 07/2013 - 01/2013
2	Carcinoma (Carcinomatosis) 12/2007 - 11/2004
1	Papillary Adenocarcinoma 08/2023
1	Endometrial Hyperplasia 08/2023
1	Adenosquamous Carcinoma 06/2023
1	Hyperthermia 01/2023
1	Fistula 01/2023
1	Polyps 01/2022
1	Staphylococcal Infections 01/2022
1	Coinfection 01/2021
1	Disease Progression 01/2019
1	Uterine Cervical Dysplasia 01/2018
1	Cysts 01/2017
1	Leiomyoma (Uterine Fibroids) 01/2016
1	Intraoperative Complications 08/2015
1	Thyroid Neoplasms (Thyroid Cancer) 02/2015
1	Ischemic Stroke 02/2014
1	Gestational Diabetes (Gestational Diabetes Mellitus) 10/2013

Drug/Important Bio-Agent (IBA)

7	PlatinumIBA 01/2023 - 01/2013
6	Matrix Metalloproteinases (MMPs)IBA 04/2010 - 07/2005
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019 - 04/2009
5	Cadherins (E-Cadherin)IBA 01/2018 - 02/2008
4	Messenger RNA (mRNA)IBA 01/2022 - 07/2012
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2008
4	Tissue Inhibitor of Metalloproteinase-2IBA 11/2008 - 04/2008
3	3' Untranslated Regions (3' UTR)IBA 10/2014 - 02/2008
3	Matrix Metalloproteinase 2 (Gelatinase A)IBA 11/2008 - 04/2008
2	LigandsIBA 01/2022 - 01/2013
2	CytokinesIBA 01/2022 - 01/2013
2	Poly (ADP-Ribose) Polymerase-1IBA 01/2022 - 12/2020
2	glutathione S-transferase M1IBA 01/2021 - 01/2019
2	Interleukin-12 Subunit p40IBA 01/2019 - 08/2018
2	Toll-Like Receptor 4IBA 05/2013 - 03/2013
1	Aromatase (CYP19)IBA 08/2023
1	Prealbumin (Transthyretin)IBA 01/2023
1	Viral ProteinsIBA 01/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2022
1	ProlactinIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Genetic Markers (Genetic Marker)IBA 12/2021
1	SubtilisinIBA 01/2021
1	Poly(A)-Binding Proteins (Poly(A)-Binding Protein)IBA 01/2021
1	Keratin-4 (Keratin 4)IBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	olaparibIBA 01/2021
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2021
1	ribosomal protein L14IBA 01/2021
1	MucinsIBA 10/2020
1	Immunoglobulins (Immunoglobulin)IBA 10/2020
1	SynucleinsIBA 01/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2019
1	Indicators and Reagents (Reagents)IBA 12/2019
1	Phosphotransferases (Kinase)IBA 12/2019
1	TropomyosinIBA 12/2019
1	Dopamine beta-HydroxylaseIBA 12/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	CateninsIBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	Intergenic DNA (Junk DNA)IBA 01/2017
1	Vascular Endothelial Growth Factor CIBA 01/2016
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2016
1	Substance PIBA 01/2016
1	Long Noncoding RNAIBA 01/2016
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 02/2015
1	Estrogen ReceptorsIBA 03/2014
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 02/2014
1	TeaIBA 12/2013
1	Transcription Factors (Transcription Factor)IBA 10/2013
1	Uric Acid (Urate)IBA 07/2013
1	Glucose (Dextrose)FDA LinkGeneric 07/2013
1	Progesterone Receptors (Progesterone Receptor)IBA 02/2013
1	Estrogens (Estrogen)FDA Link 02/2013

Therapy/Procedure

11	Hysterectomy 01/2024 - 01/2018
8	Drug Therapy (Chemotherapy) 01/2023 - 01/2013
3	Therapeutics 06/2023 - 12/2007
3	Chemoradiotherapy 05/2023 - 03/2022
2	Neoadjuvant Therapy 05/2023 - 01/2021
2	Thyroidectomy 02/2015 - 02/2015
1	Cytoreduction Surgical Procedures 01/2023
1	Hyperthermic Intraperitoneal Chemotherapy 01/2023
1	Operative Time 01/2022
1	Lymph Node Excision (Lymph Node Dissection) 10/2021
1	Laparotomy 01/2021
1	Operative Surgical Procedures 08/2015